A synthetic peptide for use as a blocking control in assays to test for specificity of GABRG2 antibody, Alternative Names: GABRG2 control peptide, GABRG2 antibody Blocking Peptide, Anti-GABRG2 Blocking Peptide, Gamma-Aminobutyric Acid Blocking Peptide, Gaba A Receptor Gamma 2 Blocking Peptide, CAE2 Blocking Peptide, ECA2 Blocking Peptide, GEFSP3 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
GABRG2
(gamma-aminobutyric Acid (GABA) A Receptor, gamma 2 (GABRG2))
Hintergrund
Gamma-aminobutyric acid (GABA), the major inhibitory neurotransmitter in the brain, mediates neuronal inhibition by binding to GABA receptors. The type A GABA receptors are pentameric chloride channels assembled from among many genetic variants of GABA(A) subunits. GABRG2 is the gamma 2 subunit of GABA(A) receptor. Mutations in this gene have been associated with epilepsy and febrile seizures.